Stem cell therapy has shown promising results in helping the heart repair itself after a heart attack, according to the largest trial of its kind. The study found that individuals who received an infusion of stem cells shortly after a heart attack were less likely to develop heart failure compared to those who received standard care. This breakthrough provides strong evidence that stem cells have the potential to aid in cardiac regeneration.
Following a heart attack, the cardiac muscle is permanently damaged and weakened, often leading to heart failure, a condition where the heart cannot pump enough blood to meet the body’s needs. Currently, there are limited treatment options available to restore cardiac function, with a transplant or heart pump being the only viable solutions.
Researchers have turned to stem cells as a potential solution due to their unique ability to transform into different cell types. Previous studies investigating the use of stem cells after a heart attack have shown mixed results. However, a recent trial conducted by Armin Attar and his team at Shiraz University in Iran focused on using mesenchymal stem cells, which can differentiate into structural cells like cartilage and fat. These stem cells also release molecules that reduce inflammation and stimulate surrounding tissues to regenerate.
In the study, mesenchymal stem cells collected from umbilical cord blood were infused into the hearts of 136 individuals within three to seven days of their first heart attack. The results were compared to a group of 260 individuals who received standard care after a heart attack. Three years later, the group treated with stem cell therapy showed a 57% lower risk of developing heart failure and a 78% lower risk of hospitalization for the condition. Additionally, they experienced significant improvements in the heart’s ability to pump blood, indicating that the treatment promotes heart tissue regeneration.
While the therapy did not reduce the risk of death during the study period, the decrease in hospital admissions is a significant outcome. It is important to note that the study primarily included male participants, and the impact of stem cell therapy on women, who are more susceptible to heart failure after a heart attack, remains unclear. However, preliminary analysis did not show significant differences based on gender.
Overall, these findings represent a significant advancement in the field of cardiac regenerative medicine. While stem cell therapy may not completely heal the heart, it provides valuable insights into the regenerative process and offers hope for improving outcomes post-heart attack. Further research is needed to explore the potential benefits of stem cell therapy in a broader population, including older adults and women, to fully understand its impact on cardiac function.
